Transfusion in Cardiac Valve Surgery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorGuangdong Provincial People's Hospital
About this trial
This prospective, randomized controlled study is aimed to figure out suitable transfusion threshold in patients undergoing cardiac valve surgery under cardiopulmonary bypass(CPB). Patients are randomly assigned to restrictive and liberal transfusion group and receive blood transfusion during and after surgery. Compare primary and secondary outcomes of two groups.
Eligibility criteria
Qualifiers
All cardiac valve surgical patients undergoing CPB, isolated valve procedures Informed consent obtained
Disqualifiers
Pregnant or maternal women Age less than 18 years or more than 80 years Undergo coronary artery bypass or large cardiac vessels procedure Emergencies Have been attended other researches Unable to receive blood for religious reasons Drug addict or malignant tumor patient
Trial design
Treatments tested in this trial
- Restrictive Transfusion Strategy
- Liberal Transfusion Strategy
Treatment groups
1,600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov